Sibon, David <br/><br/>
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.  [electronic resource] 

 -  British journal of haematology  Apr 2011 
 - 191-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2011.08594.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bleomycin--administration & dosage<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Hodgkin Disease--mortality<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Prospective Studies<br/>Recurrence<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Transplantation, Autologous<br/>Vinblastine--administration & dosage